FREE Account Opening + No Clearing Fees
Loading...

Eris Lifesciences IPO vs PSP Projects IPO

Comparision between Eris Lifesciences IPO and PSP Projects IPO.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while PSP Projects IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Eris Lifesciences IPO PSP Projects IPO
Logo Eris Lifesciences IPO Logo PSP Projects IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers Axis Capital Limited

Citigroup Global Markets India Private Limited

Credit Suisse Securities (India) Private Limited
Karvy Investor Services Limited

Motilal Oswal Investment Advisors Limited
Registrar Link Intime India Private Ltd Kfin Technologies Limited
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the PSP Projects IPO is up to ₹211.68 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of PSP Projects IPO is ₹210.00 per share.

  Eris Lifesciences IPO PSP Projects IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹600.00 per share ₹205.00 per share
Issue Price (Upper) ₹603.00 per share ₹210.00 per share
Issue Price (Final) ₹603.00 per share ₹210.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 24 shares 70 shares
Fresh Issue Size 72,00,000 shares
Fresh Issue Size (Amount)
OFS Issue Size 2,88,75,000 shares 28,80,000 shares
OFS Issue Size (Amount)
Issue Size Total 2,88,75,000 shares 1,00,80,000 shares
Issue Size Total (Amount) up to ₹1,741.16 Cr up to ₹211.68 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while PSP Projects IPO opens on May 17, 2017. The closing date of Eris Lifesciences IPO and PSP Projects IPO is Jun 20, 2017, and May 19, 2017, respectively.

  Eris Lifesciences IPO PSP Projects IPO
Anchor Bid Date
Issue Open Jun 16, 2017 May 17, 2017
Issue Close Jun 20, 2017 May 19, 2017
Basis Of Allotment (Tentative) Jun 23, 2017 May 24, 2017
Initiation of Refunds (Tentative) Jun 27, 2017 May 26, 2017
Credit of Share (Tentative) Jun 28, 2017 May 26, 2017
Listing date (Tentative) Jun 29, 2017 May 29, 2017
Anchor Lockin End date 1 Jul 23, 2017 Jun 23, 2017
Anchor Lockin End date 2 Sep 21, 2017 Aug 22, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to PSP Projects IPO P/E ratio of .

  Eris Lifesciences IPO PSP Projects IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Summary of financial Information
Particulars For the year/period ended (in Rs. Million)
31-Dec-16 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 2,741.50 2,287.13 1,863.78 1,362.71 1,009.60 918.53
Total Revenue 2,494.15 4,677.14 2,869.67 2,147.97 2,609.69 1,807.53
Profit After Tax (PAT) 214.83 249.31 140.54 100.70 122.50 83.52
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in PSP Projects IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 30,24,000 shares in PSP Projects IPO.

  Eris Lifesciences IPO PSP Projects IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,17,500 shares 30,24,000 shares
NII 43,08,750 shares 15,12,000 shares
RII 28,72,500 shares 10,08,000 shares
Employee 1,50,000 shares
Others
Total 1,59,48,750 shares 55,44,000 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas PSP Projects IPO subscribed 8.58x.

  Eris Lifesciences IPO PSP Projects IPO
QIB (times) 4.68x 8.38x
NII (times) 0.45x 10.39x
Big NII (times)
Small NII (times)
RII (times) 3.51x 6.47x
Employee (times) 0.86x
Other (times)
Total (times) 3.29x 8.58x

Comments

Add a public comment...